Next |
home / stock / tara / tara message board
Subject | By | Source | When |
---|---|---|---|
OrbiMed Advisors now holds 6%+ .. Opaleye 25+, | stocksrising | investorshub | 02/15/2023 3:14:25 AM |
Opal almost at 25% ownership! Continue to scoop | stocksrising | investorshub | 12/28/2021 4:51:06 AM |
Opal continues open market accumulation around 7ish:)see recent | stocksrising | investorshub | 11/20/2021 7:13:30 AM |
Oppenheimer Maintains Outperform on Protara Therapeutics, Raises Price | stocksrising | investorshub | 11/08/2021 1:23:47 PM |
True!! This piggy never holds its gains, but | stocksrising | investorshub | 10/14/2021 3:15:55 PM |
nothing to cheer about. | alchemytrader | investorshub | 10/13/2021 3:20:48 PM |
4.2mm is low volume? | stocksrising | investorshub | 10/12/2021 1:29:31 PM |
low volume... | alchemytrader | investorshub | 10/12/2021 12:51:19 PM |
$TARA Protara Therapeutics Announces FDA Clearance of Investigational | TheFinalCD | investorshub | 10/12/2021 11:03:32 AM |
Big news @ www.clinicalstrials.com | stocksrising | investorshub | 08/18/2021 2:05:09 PM |
Balance Sheet still shows $145m ( slow burn) | stocksrising | investorshub | 08/05/2021 1:35:59 PM |
I guess not. I got a bit | ok2buy | investorshub | 06/30/2021 1:22:27 PM |
Is something up with $TARA today? News? | ok2buy | investorshub | 06/30/2021 11:42:26 AM |
Nice insider buy!! Chief Medical Officer Spent ~$100k | stocksrising | investorshub | 06/14/2021 11:00:32 PM |
Nice insider buy!! Chief Medical Officer Spent ~$100k | stocksrising | investorshub | 06/14/2021 10:59:42 PM |
Same here, holding and slowly adding for a | stocksrising | investorshub | 05/13/2021 11:59:04 AM |
This one is beat up. Expectations on | ok2buy | investorshub | 05/03/2021 6:46:59 PM |
2 Virtual Conferences upcoming, should be interesting! | stocksrising | investorshub | 02/04/2021 11:22:58 PM |
Crazy volatility, great if a trader and catch | stocksrising | investorshub | 12/23/2020 3:33:26 AM |
Boat load of cash in the coffers | dinogreeves | investorshub | 07/28/2020 1:23:26 PM |
News, Short Squeeze, Breakout and More Instantly...
ArTara Therapeutics Inc. Company Name:
TARA Stock Symbol:
NASDAQ Market:
Reported positive data from three-month evaluable CIS patients treated across ongoing TARA-002 clinical program in NMIBC Preliminary data from six-month evaluable patients in ADVANCED-2 trial of TARA-002 in NMIBC expected in 2H 2024 Reached alignment with FDA on registrational p...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
Friday, Protara Therapeutics Inc (NASDAQ:TARA) shared data from three-month evaluable carcinoma in situ (CIS) patients treated across TAR...